InsiderClue
← All stocks

Olema Pharmaceuticals, Inc.

OLMA Net buying
CIK 0001750284 #2588 in the set updated 20 Sep 2026
Bought (120 mo)
$88.75M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$95.43M
$3.55M on a plan · $22.47M straight out of an exercise
Sold at will
$69.42M
65 of 127 sales
Net
−$6.69M
+$19.33M against sales at will

By person

19 insiders · 162 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BVF PARTNERS L P/IL entity
Director
$44.14M (11)
—
+$44.14M
547,082
0.6253%
$6.41M
—
Paradigm Biocapital Advisors LP entity
10% owner
$1.16M (1)
$35.80M (2)
−$34.64M
783,118
0.8950%
$9.17M
−74.6%
Graham G. Walmsley
Director
$33.64M (6)
$22.18M (3)
+$11.46M
2,568,875
2.94%
$30.09M
+237.3%
Cormorant Asset Management, LP entity
Former 10% Owner
$8.08M (1)
—
+$8.08M
3,270,544
3.74%
$38.31M
—
Zojwalla Naseem
CHIEF MEDICAL OFFICER
—
$7.99M (10) scheduled
−$7.99M
4,488
0.0051%
$52.57K
−80.7%
CLARK IAN T
Director
—
$7.87M (3) scheduled
−$7.87M
0
0.0000%
$0.00
—
Harmon Cyrus
Director
—
$6.37M (50)
−$6.37M
941,826
1.08%
$11.03M
−8.2%
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
—
$5.61M (20) scheduled
−$5.61M
842,453
0.9628%
$9.87M
+38.8%
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
— (2)
$3.57M (8)
−$3.57M
139,727
0.1597%
$1.64M
+644.4%
Horn Kinney
Chief Business Officer
—
$2.98M (16) scheduled
−$2.98M
2,458
0.0028%
$28.79K
0.0%
Bohen Sean
PRESIDENT AND CEO
—
$2.11M (12)
−$2.11M
237,650
0.2716%
$2.78M
+806.1%
Bain Capital Life Sciences Investors, LLC entity
10% owner
$1.73M (1)
—
+$1.73M
4,300,000
4.91%
$50.37M
−42.7%
Mitchell Shawnte
CHIEF LEGAL OFFICER
—
$951.50K (3) scheduled
−$951.50K
0
0.0000%
$0.00
—
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
—
—
—
1,725,406
1.97%
$20.21M
—
Kushner Peter J.
CHIEF SCIENTIFIC OFFICER
—
—
—
1,431,672
1.64%
$16.77M
+54.1%
RAPPAPORT ANDREW
Director
—
—
—
866,979
0.9909%
$10.16M
+68.8%
MCCORMICK FRANK
Director
—
—
—
275,373
0.3147%
$3.23M
+390.4%
BUTITTA CYNTHIA M
Director
—
—
—
83,876
0.0959%
$982.52K
—
Austin Sasha Lu
VP of Finance and Controller
—
—
—
16,188
0.0185%
$189.63K
+260.7%

Individual transactions

65
Insider
Date
Role
Action
Shares
Price
Amount
Harmon Cyrus
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Harmon Cyrus
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Harmon Cyrus
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Kovacs Shane William Charles
15 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
100,000
$28.73
$2.87M
Harmon Cyrus
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
Kovacs Shane William Charles
13 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
3,822
$28.01
$107.05K
Myles David C.
12 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sell indirect
10,000
$28.34
$283.40K
Harmon Cyrus
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,046
$31.39
$189.78K
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
43,729
$30.40
$1.33M
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
1,225
$28.08
$34.40K
Harmon Cyrus
18 Sep 2025
Director
Sell indirect
3,086
$8.32
$25.68K
Harmon Cyrus
18 Sep 2025
Director
Sell
10,000
$8.33
$83.30K
Harmon Cyrus
16 Sep 2025
Director
Sell indirect
1,914
$8.08
$15.47K
Harmon Cyrus
16 Sep 2025
Director
Sell
10,000
$8.04
$80.40K
Graham G. Walmsley
17 Dec 2024
Director
Sell indirect
700,761
$6.75
$4.73M
Bohen Sean
11 Dec 2024
PRESIDENT AND CEO
Sell
1,267
$9.39
$11.90K
Bohen Sean
11 Dec 2024
PRESIDENT AND CEO
Sell
55,907
$8.66
$484.15K
Kovacs Shane William Charles
11 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
406
$9.39
$3.81K
Kovacs Shane William Charles
11 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
17,950
$8.66
$155.45K
Zojwalla Naseem
11 Dec 2024
CHIEF MEDICAL OFFICER
Sell
320
$9.39
$3.00K
Zojwalla Naseem
11 Dec 2024
CHIEF MEDICAL OFFICER
Sell
14,202
$8.66
$122.99K
Myles David C.
11 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
300
$9.39
$2.82K
Myles David C.
11 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
13,314
$8.66
$115.30K
Harmon Cyrus
11 Dec 2024
Director
Sell
179
$9.39
$1.68K
Harmon Cyrus
11 Dec 2024
Director
Sell
7,958
$8.66
$68.92K
Bohen Sean
10 Dec 2024
PRESIDENT AND CEO
Sell
52,328
$9.37
$490.31K
Kovacs Shane William Charles
10 Dec 2024
CH. OPERATING & FINANCIAL OFF.
Sell
16,803
$9.37
$157.44K
Zojwalla Naseem
10 Dec 2024
CHIEF MEDICAL OFFICER
Sell
13,283
$9.37
$124.46K
Myles David C.
10 Dec 2024
CH. DISCOV. & NON-CLIN DEV OFF
Sell
12,452
$9.38
$116.80K
Harmon Cyrus
10 Dec 2024
Director
Sell
8,256
$9.37
$77.36K
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell indirect
529,501
$14.92
$7.90M
Paradigm Biocapital Advisors LP
1 Aug 2024
10% owner
Sell indirect
1,870,499
$14.92
$27.90M
Graham G. Walmsley
4 Jun 2024
Director
Sell indirect
475,000
$14.85
$7.05M
Graham G. Walmsley
4 Jun 2024
Director
Sell indirect
700,000
$14.85
$10.40M
Harmon Cyrus
29 Dec 2023
Director
Sell
2,500
$14.10
$35.25K
Harmon Cyrus
29 Dec 2023
Director
Sell
22,500
$13.30
$299.25K
Kovacs Shane William Charles
22 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
9,145
$13.89
$127.02K
Bohen Sean
22 Nov 2023
PRESIDENT AND CEO
Sell
27,932
$13.90
$388.25K
Myles David C.
22 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,653
$13.89
$92.41K
Zojwalla Naseem
22 Nov 2023
CHIEF MEDICAL OFFICER
Sell
7,095
$13.89
$98.55K
Harmon Cyrus
22 Nov 2023
Director
Sell
3,989
$13.90
$55.45K
Kovacs Shane William Charles
21 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
700
$15.27
$10.69K
Kovacs Shane William Charles
21 Nov 2023
CH. OPERATING & FINANCIAL OFF.
Sell
8,897
$14.83
$131.94K
Bohen Sean
21 Nov 2023
PRESIDENT AND CEO
Sell
2,602
$15.29
$39.78K
Bohen Sean
21 Nov 2023
PRESIDENT AND CEO
Sell
26,691
$14.84
$396.09K
Myles David C.
21 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
200
$15.32
$3.06K
Myles David C.
21 Nov 2023
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,776
$14.87
$100.76K
Zojwalla Naseem
21 Nov 2023
CHIEF MEDICAL OFFICER
Sell
200
$15.33
$3.07K
Zojwalla Naseem
21 Nov 2023
CHIEF MEDICAL OFFICER
Sell
7,261
$14.83
$107.68K
Harmon Cyrus
21 Nov 2023
Director
Sell
4,192
$14.86
$62.29K
Harmon Cyrus
8 Jun 2023
Director
Sell
10,000
$6.30
$63.00K
Harmon Cyrus
6 Jun 2023
Director
Sell
5,000
$6.30
$31.48K
Harmon Cyrus
5 Jun 2023
Director
Sell
5,000
$6.05
$30.23K
Myles David C.
10 Dec 2021
CHIEF DEVELOPMENT OFFICER
Sell
10,000
$10.30
$103.00K
Harmon Cyrus
29 Nov 2021
CHIEF TECHNOLOGY OFFICER
Sell
400
$24.76
$9.90K
Harmon Cyrus
19 Oct 2021
CHIEF TECHNOLOGY OFFICER
Sell
4,555
$28.20
$128.45K
Harmon Cyrus
19 Oct 2021
CHIEF TECHNOLOGY OFFICER
Sell
7,445
$27.85
$207.34K
Harmon Cyrus
20 Sep 2021
CHIEF TECHNOLOGY OFFICER
Sell
12,000
$26.30
$315.60K
Harmon Cyrus
19 Aug 2021
CHIEF TECHNOLOGY OFFICER
Sell
12,000
$24.97
$299.64K
Harmon Cyrus
20 Jul 2021
CHIEF TECHNOLOGY OFFICER
Sell
4,123
$25.63
$105.67K
Harmon Cyrus
19 Jul 2021
CHIEF TECHNOLOGY OFFICER
Sell
7,877
$24.83
$195.59K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
600
$26.30
$15.78K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
1,990
$25.59
$50.92K
Harmon Cyrus
18 Jun 2021
CHIEF TECHNOLOGY OFFICER
Sell
9,410
$24.54
$230.92K
Show all 162 transactions →

What was left out

Form 4 filings counted 203
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 36
Sales at will 65
Transactions with no price 2
Shares from compensation/vesting 24,931,528
Sales filed before the plan box existed 11
History held since 19 Nov 2020